Bausch Health
324 hedge funds and large institutions have $3.58B invested in Bausch Health in 2020 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 101 increasing their positions, 102 reducing their positions, and 37 closing their positions.
62% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 37
32% more call options, than puts
Call options by funds: $180M | Put options by funds: $136M
7% more funds holding
Funds holding: 303 → 324 (+21)
1% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 102
1.64% less ownership
Funds ownership: 65.99% → 64.35% (-1.6%)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
17% less capital invested
Capital invested by funds: $4.29B → $3.58B (-$708M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$77.5M |
| 2 |
CCA
Canyon Capital Advisors
Dallas,
Texas
|
+$51.8M |
| 3 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$42.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.8M |
| 5 |
Barclays
London,
United Kingdom
|
+$39.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$295M |
| 2 |
Renaissance Technologies
New York
|
-$79.8M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$43.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.3M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$30.4M |
BHC Hedge Fund Activity: Q3 2020 in Review
324 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2020, worth a combined $3.58B — down 17% from $4.29B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new BHC positions and 37 closed out — a net gain of 23 holders — while 101 added to existing stakes and 102 trimmed.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $77.5M. The largest seller was Fidelity International, cutting an estimated $295M.
- 324 institutional investors held Bausch Health (BHC) as of Q3 2020, up from 303 in Q2 2020.
- Funds reported $3.58B of Bausch Health stock for Q3 2020, down 17% quarter-over-quarter.
- 60 funds opened new Bausch Health positions in Q3 2020 and 37 closed out, a net change of +23 holders.
- The largest Bausch Health buyer in Q3 2020 was Camber Capital Management, an estimated $77.5M added.
- The largest Bausch Health seller in Q3 2020 was Fidelity International, an estimated $295M sold.
Based on aggregated 13F filings for Q3 2020.